I thought so at first but I am not really sure Bustus.
You see Viatris has different pricing and I am not 100% sure how it works. HIV pricing for LMI countries works differently but I am not 100% sure how.
But anyway let's assume that each device is $4 profit ( so... the large portion of profits came from 100K devices, total quarter $400K dollars ) and 200K devices were added to this, ( $800K) that's 1.2 Million for the quarter, which is pretty good.
But pregnancy and HIV I am sure are priced differently so, who knows the real story.
In any event the sales continue to grow quarter on quarter.
AT1 FY21 - General Discussion + FA, page-2343
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 497908 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 67200 | 3 |
View Market Depth
| Last trade - 16.12pm 02/08/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |
Day chart unavailable